Αποτελέσματα Αναζήτησης
14 Μαρ 2024 · the estimated 189,000 People living with HIV by the end of 2023 is projected to increase by more than two times to 401,700 PLHIV by 2030. Source: AIDS Epidemic Model (AEM)-Spectrum, May 2023. The Philippine HIV Epidemic is largely among MSM & TGW. The youth remains the driver of new infections.
Before the COVID-19 pandemic, the Philippines enacted a new HIV law that lowered the age of HIV testing without parental consent, incorporated HIV testing into prenatal care, and expanded public health insurance coverage to HIV treatment. 1 Although the number of new HIV infections in the Philippines decreased between 2019 and 2020, 2 officials ...
16 Ιουλ 2021 · These guidelines bring in the most recent guidance on HIV testing strategies - the entry point for HIV prevention and treatment - and include comprehensive guidance on infant diagnosis. Key recommendations are presented on rapid antiretroviral therapy (ART) initiation and the use of dolutegravir.
9 Ιουλ 2022 · AO 2022-24 Guidelines on Differentiated Treatment for People Living with Human Immunodeficiency Virus (PLHIV) and Prophylaxis for HIV-Exposed Infants Loading… Taking too long?
23 Ιουλ 2023 · New WHO guidance and an accompanying Lancet systematic review released today describe the role of HIV viral suppression and undetectable levels of virus in both improving individual health and halting onward HIV transmission.
A crucial target in addressing the HIV/AIDS epidemic is the elimination of vertical transmission across the globe.1 This remains a challenge in low-resource countries with fast-growing HIV infection rates such as the Philippines, where only 26% of women living with HIV receive antiretroviral treatment for the prevention of vertical transmission.
In this review, we provide an overview on currently available anti-HIV drugs and the latest developments in antiretroviral therapy, focused on new antiretroviral agents acting on known and unexploited antiviral targets, prevention therapies aimed to improve available drug combinations, and research on new long-acting therapies, particularly ...
